Cancer genomics and epigenetics focus on the genetic and molecular alterations that drive cancer development and progression. Genomic changes, such as mutations and gene amplifications, play a central role in the initiation of cancer, while epigenetic modifications can influence gene expression without altering the DNA sequence. This session will explore the latest discoveries in cancer genomics and epigenetics, highlighting their potential in early detection, targeted therapy, and personalized medicine, which are revolutionizing cancer treatment approaches.
Tracks:
Track 19-1: Genomic Alterations in Cancer
Track 19-2: Epigenetic Modifications
Track 19-3: Next-Generation Sequencing
Track 19-4: Cancer Biomarkers
Track 19-5: Therapeutic Implications
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
